Novo Nordisk’s Forma Buy Builds On Foothold In Rare Blood Disorders

 
• By Jessica Merrill
  
sickle cell 2
Novo Nordisk is acquiring Forma, investing in sickle cell disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business